XML 27 R29.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

3 Months Ended

Mar. 31, 2013

Revenues, Cost Of Services And Products, And Gross Margins For Operating Segments


	Three Months Ended
	March 31,
	2013		2012
Revenues:
Medical devices	$	19,796	$	16,454
Preservation services		15,677		15,659
Other^a		63		188
Total revenues		35,536		32,301

Cost of products and preservation services:
Medical devices		3,465		2,513
Preservation services		8,795		8,496
Total cost of products and preservation services		12,260		11,009

Gross margin:
Medical devices		16,331		13,941
Preservation services		6,882		7,163
Other^a		63		188
Total gross margin	$	23,276	$	21,292

Summary Of Net Revenues By Product


	Three Months Ended
	March 31,
	2013		2012
Products:
BioGlue and BioFoam	$	15,464	$	13,696
PerClot		864		644
Revascularization technologies		2,191		2,114
HeRO Graft		1,277		--
Total products		19,796		16,454

Preservation services:
Cardiac tissue		6,645		7,080
Vascular tissue		9,032		8,579
Total preservation services		15,677		15,659

Other^a		63		188
Total revenues	$	35,536	$	32,301

___________________

^a For the three months ended March 31, 2013 and 2012 the “Other” designation includes grant revenue.

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details